Nutrition and the HIV-associated lipodystrophy syndrome

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Nutrition research reviews

• Publication date

  2012-11-23

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1017/S0954422411000138PMID 23174511
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global guideline for type 2 diabetes.

  2014cited by this paper
• Faculty Opinions recommendation of Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2013cited by this paper
• Prevalence of Lipodystrophy and Dyslipidemia among Patients with HIV Infection on Generic ART in Rural South India

  2012cited by this paper
• Can a Mediterranean diet reduce the effects of lipodystrophy syndrome in people living with HIV? A pilot randomised controlled trial.

  2011cited by this paper
• Prevalence of and risk factors for lipodystrophy among HIV-infected patients receiving combined antiretroviral treatment in the Asia-Pacific region: results from the TREAT Asia HIV Observational Database (TAHOD).

  2011cited by this paper
• The assessment of metabolic syndrome in UK patients with HIV using two different definitions: CREATE 2 study

  2011cited by this paper
• The effects of enfuvirtide therapy on body composition and metabolic parameters over 48 weeks in the TORO body imaging substudy *

  2011cited by this paper
• Growth hormone axis treatments for HIV‐associated lipodystrophy: a systematic review of placebo‐controlled trials

  2011cited by this paper
• Combination of niacin and fenofibrate with lifestyle changes improves dyslipidemia and hypoadiponectinemia in HIV patients on antiretroviral therapy: results of "heart positive," a randomized, controlled trial.

  2011cited by this paper
• Differential Effects of Rosiglitazone and Metformin on Postprandial Lipemia in Patients With HIV-Lipodystrophy

  2011cited by this paper
• Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients

  2011cited by this paper
• National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants.

  2011cited by this paper
• Disorders of fat partitioning in treated HIV-infection.

  2011cited by this paper
• Association Between Human Immunodeficiency Virus Infection and Stiffness of the Common Carotid Artery

  2010cited by this paper
• Both HIV-infection and long-term antiretroviral therapy are associated with increased common carotid intima-media thickness in HIV-infected adolescents and young adults.

  2010cited by this paper
• High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome

  2010cited by this paper
• Human immunodeficiency virus treatment-induced adipose tissue pathology and lipoatrophy: prevalence and metabolic consequences.

  2010cited by this paper
• Cardiovascular disease risk profiles.

  2010cited by this paper
• Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial

  2010cited by this paper
• Endothelial function is impaired in HIV-infected patients with lipodystrophy

  2010cited by this paper
• The Effects of Exercise Training on Metabolic and Morphological Outcomes for People Living With HIV: A Systematic Review of Randomised Controlled Trials

  2010cited by this paper
• Large particle hyaluronic acid for the treatment of facial lipoatrophy in HIV‐positive patients: 3‐year follow‐up study

  2010cited by this paper
• No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trial *

  2010cited by this paper
• Drug-induced lipotoxicity: lipodystrophy associated with HIV-1 infection and antiretroviral treatment.

  2010cited by this paper
• Prevalence of and Risk Factors for Pre-Diabetes in HIV-1-Infected Patients in Bangkok, Thailand

  2010cited by this paper
• Antiretroviral drugs.

  2010cited by this paper
• Setting the stage: current state of affairs and major challenges.

  2010cited by this paper
• Relationship of Body Composition, Metabolic Status, Antiretroviral Use, and HIV Disease Factors to Endothelial Dysfunction in HIV-Infected Subjects

  2010cited by this paper
• Premature Senescence of Vascular Cells Is Induced by HIV Protease Inhibitors: Implication of Prelamin A and Reversion by Statin

  2010cited by this paper
• Coronary aging in HIV-infected patients.

  2010cited by this paper
• The global burden of diabetes and its complications: an emerging pandemic

  2010cited by this paper
• Dietary calcium, dairy food intake and metabolic abnormalities in HIV-infected individuals.

  2010cited by this paper
• Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America.

  2010cited by this paper
• A Meta-Analysis of Six Placebo-Controlled Trials of Thiazolidinedione Therapy for HIV Lipoatrophy

  2010cited by this paper
• Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages.

  2010cited by this paper
• Association Between Abacavir Exposure and Increased Risk for Cardiovascular Disease in Patients with Human Immunodeficiency Virus

  2010cited by this paper
• Position of the American Dietetic Association: Nutrition Intervention and Human Immunodeficiency Virus Infection.

  2010cited by this paper
• Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review of the last 20 years (1989-2009).

  2010cited by this paper
• Premature Senescence of Vascular Cells Is Induced by HIV Protease Inhibitors

  2010cited by this paper
• Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study

  2010cited by this paper
• Risk factors related to hypertension among patients in a cohort living with HIV/AIDS.

  2010cited by this paper
• Adherence to Mediterranean diet is favorably associated with metabolic parameters in HIV-positive patients with the highly active antiretroviral therapy-induced metabolic syndrome and lipodystrophy.

  2009cited by this paper
• Correction of facial lipoatrophy using autologous fat transplants in HIV‐infected adolescents

  2009cited by this paper
• Carotid Intima-Media Thickness and Arterial Stiffness in HIV-Infected Patients: The Role of HIV, Antiretroviral Therapy, and Lipodystrophy

  2009cited by this paper
• Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy.

  2009cited by this paper
• Improvement in Lipid Profiles in Antiretroviral-Experienced HIV-Positive Patients With Hyperlipidemia After a Switch to Unboosted Atazanavir

  2009cited by this paper
• Antiretroviral therapy with or without protease inhibitors impairs postprandial TAG hydrolysis in HIV-infected men

  2009cited by this paper
• Hypoadiponectinemia in lipodystrophic HIV individuals: a metabolic marker of subclinical cardiac damage.

  2009cited by this paper
• Metabolic syndrome in Black people of the African diaspora: the paradox of current classification, definition and criteria.

  2009cited by this paper
• Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism.

  2009cited by this paper
• Evolving perspectives on HIV-associated lipodystrophy syndrome: moving from lipodystrophy to non-infectious HIV co-morbidities.

  2009cited by this paper
• HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial

  2009cited by this paper
• Immediate versus Delayed Surgical Intervention for Reconstructive Therapy of HIV-Associated Facial Lipoatrophy: A Randomized Open-Label Study

  2009cited by this paper
• HIV infection and antiretroviral treatment: a "two-hit" model for arterial stiffness?

  2009cited by this paper
• Effect of L-Acetylcarnitine on Body Composition in HIV-related Lipodystrophy

  2009cited by this paper
• The metabolic syndrome, an epidemic among HIV-infected patients on HAART.

  2009cited by this paper
• Cardiovascular disease risk management in HIV patients, experiences from Greater Manchester

  2009cited by this paper
• Baseline Lipid Levels Rather Than the Presence of Reported Body Shape Changes Determine the Degree of Improvement in Lipid Levels After Switching to Atazanavir

  2009cited by this paper
• Heterologous fat transplantation for the treatment of HIV-related facial lipoatrophy.

  2009cited by this paper
• Disorders of body fat distribution in HIV-1-infected patients.

  2009cited by this paper
• Coronary aging in HIV-infected patients.

  2009cited by this paper
• Lipoatrophy and lipohypertrophy are independently associated with hypertension *

  2009cited by this paper
• Lipodystrophy and Metabolic Disorders in HIV-1-Infected Adults on 4- to 9-Year Antiretroviral Therapy in Senegal: A Case-Control Study

  2009cited by this paper
• Fatty liver and hyperlipidemia in a cohort of HIV-positive Africans on highly active antiretroviral therapy.

  2009cited by this paper
• Adherence to the Mediterranean diet is associated with a lower risk of body-shape changes in Croatian patients treated with combination antiretroviral therapy

  2009cited by this paper
• Effects of Ritonavir on Adipocyte Gene Expression: Evidence for a Stress‐related Response

  2008cited by this paper
• Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000–2006

  2008cited by this paper
• Incidence of lipodystrophy and metabolic disorders in patients starting non-nucleoside reverse transcriptase inhibitors in Benin

  2008cited by this paper
• HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options.

  2008cited by this paper
• Mechanism of action of niacin.

  2008cited by this paper
• Beyond blood pressure: Arterial stiffness as a new biomarker of cardiovascular disease.

  2008cited by this paper
• Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.

  2008cited by this paper
• Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men

  2008cited by this paper
• Efficacy of Contact Lens Systems Against Recent Clinical and Tap Water Acanthamoeba Isolates

  2008cited by this paper
• Uridine supplementation in HIV lipoatrophy: pilot trial on safety and effect on mitochondrial indices

  2008cited by this paper
• The effect of strength and endurance training on insulin sensitivity and fat distribution in human immunodeficiency virus-infected patients with lipodystrophy.

  2008cited by this paper
• Fish Oil and Fenofibrate for the Treatment of Hypertriglyceridemia in HIV-Infected Subjects on Antiretroviral Therapy: Results of ACTG A5186

  2008cited by this paper
• Prevalence and Predictors of Metabolic Syndrome Among HIV-Infected and HIV-Uninfected Women in the Women's Interagency HIV Study

  2008cited by this paper
• Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s.

  2008cited by this paper
• Cardiovascular manifestations in human immunodeficiency virus-infected patients.

  2008cited by this paper
• Assessing the long-term viability of facial fat grafts: an objective measure using computed tomography.

  2008cited by this paper
• Antiretroviral therapy and the human immunodeficiency virus – improved survival but at what cost?

  2008cited by this paper
• A Prospective Study of Body Fat Redistribution, Lipid, and Glucose Parameters in HIV-Infected Patients Initiating Combination Antiretroviral Therapy

  2008cited by this paper
• Improvements in Subcutaneous Fat, Lipid Profile, and Parameters of Mitochondrial Toxicity in Patients with Peripheral Lipoatrophy When Stavudine is Switched to Tenofovir (LIPOTEST Study)

  2008cited by this paper
• Clinical and biochemical evaluation of HIV-related lipodystrophy in an ambulatory population from the Hospital Universitário Cassiano Antonio de Morais, Vitória, ES, Brazil.

  2008cited by this paper
• Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy.

  2008cited by this paper
• Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients

  2008cited by this paper
• Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy.

  2008cited by this paper
• Contribution of Mitochondrial Dysfunction and Oxidative Stress to Cellular Premature Senescence Induced by Antiretroviral Thymidine Analogues

  2008cited by this paper
• Excisional lipectomy for HIV-associated cervicodorsal lipodystrophy.

  2008cited by this paper
• HIV Lipodystrophy Syndrome

  2008cited by this paper
• Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid.

  2007cited by this paper
• Pathogenesis of lipodystrophy and lipid abnormalities in patients taking antiretroviral therapy.

  2007cited by this paper
• Short-term energy restriction reduces resting energy expenditure in patients with HIV lipodystrophy and hypermetabolism.

  2007cited by this paper
• Antiretroviral Drugs

  2007cited by this paper
• Mitochondrial Toxicity of Indinavir, Stavudine and Zidovudine Involves Multiple Cellular Targets in white and brown adipocytes

  2007cited by this paper
• HIV-associated adipose redistribution syndrome (HARS): definition, epidemiology and clinical impact

  2007cited by this paper
• Some HIV Antiretrovirals Increase Oxidative Stress and Alter Chemokine, Cytokine or Adiponectin Production in Human Adipocytes and Macrophages

  2007cited by this paper
• Mitochondrial Toxicity of Tenofovir, Emtricitabine and Abacavir Alone and in Combination with Additional Nucleoside Reverse Transcriptase Inhibitors

  2007cited by this paper
• High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda.

  2007cited by this paper

• Identification of novel genetic variations in ABCB6 and GRN genes associated with HIV-associated lipodystrophy.

  2024cites this paper
• Patients living with HIV have quantitatively inadequate food consumption

  2023cites this paper
• Effect of genetic variations in drug transporters, metabolizing enzyme and regulatory genes on the development of HIV‐associated lipodystrophy

  2023cites this paper
• Comparative analysis of MTP -493G/T and ABCG2 34G/A polymorphisms and theirs expression in HIV-associated lipodystrophy patients

  2023cites this paper
• Nutritional aberration and related morphological disorders among patients with human immunodeficiency virus infection on combination antiretroviral therapy (cART) in Ghana: A retrospective study

  2022cites this paper
• Self-reported HIV/HAART-associated Lipodystrophy and Modifiable Risk Factors for Cardiovascular Disease

  2020cites this paper
• Investigation of SIRT1 gene variants in HIV-associated lipodystrophy and metabolic syndrome

  2020cites this paper
• Association of the polymorphisms of the genes APOC3 (rs2854116), ESR2 (rs3020450), HFE (rs1799945), MMP1 (rs1799750) and PPARG (rs1801282) with lipodystrophy in people living with HIV on antiretroviral therapy: a systematic review

  2020cites this paper
• Mechanistic Links Between Obesity, Diabetes, and Blood Pressure: Role of Perivascular Adipose Tissue.

  2019cites this paper
• DNA polymerase-γ hypothesis in nucleoside reverse transcriptase-induced mitochondrial toxicity revisited: A potentially protective role for citrus fruit-derived naringenin?

  2019cites this paper
• Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells

  2019cites this paper
• Impaired Adipogenesis and Dysfunctional Adipose Tissue in Human Hypertrophic Obesity.

  2018cites this paper
• Dietary Patterns and Physical Activity Correlate With Total Cholesterol Independently of Lipid-Lowering Drugs and Antiretroviral Therapy in Aging People Living With Human Immunodeficiency Virus

  2018cites this paper
• Chapter 6 The Impact of Modern Antiretroviral Therapy on Lipid Metabolism of HIV-1 Infected Patients

  2017cites this paper
• Heart fat in HIV: marker or mediator of risk?

  2017cites this paper
• Body fat redistribution and changes in lipid and glucose metabolism in people living with HIV/AIDS.

  2017cites this paper
• Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome and Lipodystrophy: Pathophysiology and Current Therapeutic Interventions

  2017influential citation
• Lipodystrophy syndrome in HIV-infected patients – a cohort study in Lower Silesia, Poland

  2017cites this paper
• DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long‐term nucleo(t)side analogs therapy

  2017cites this paper
• Title: Conjugated linoleic acid isomers exert differential effects on an adipocyte model of HIV-associated lipodystrophy Running title: Conjugated linoleic acid and HIV-associated lipodystrophy

  2017cites this paper
• Conjugated Linoleic Acid Isomers Exert Differential Effects on an Adipocyte Model of HIV-associated Lipodystrophy.

  2017cites this paper
• Naringin prevents HIV-1 protease inhibitors-induced metabolic complications in vivo

  2017cites this paper
• Naringin protects against HIV-1 protease inhibitors-induced pancreatic β-cell dysfunction and apoptosis.

  2016cites this paper
• Management of Cardiovascular and Metabolic Alterations in HIV positive patients

  2016cites this paper
• Efavirenz and ritonavir-boosted lopinavir use exhibited elevated markers of atherosclerosis across age groups in people living with HIV in Ethiopia.

  2016cites this paper
• A characterisation of low-grade inflammation and metabolic complications in HIV-infected patients.

  2016cites this paper
• Síndrome de lipodistrofia y calidad de vida en personas que viven con VIH en Tratamiento Antirretroviral de Gran Actividad (TARGA) en una institución de seguridad social.

  2016cites this paper
• The Impact of Modern Antiretroviral Therapy on Lipid Metabolism of HIV-1 Infected Patients

  2015cites this paper
• Prevalence and associations of lipodystrophy in HIV-infected outpatients in two London clinics

  2015cites this paper
• Trauma and Immunosuppressive Diseases

  2015cites this paper
• Nutritional Status and Lipid Profile in HIV-Infected Adults.

  2015cites this paper
• Cardiovascular Complications of HIV-Associated Immune Dysfunction

  2015cites this paper
• Current Efavirenz (EFV) or Ritonavir-Boosted Lopinavir (LPV/r) Use Correlates with Elevate Markers of Atherosclerosis in HIV-Infected Subjects in Addis Ababa, Ethiopia

  2015cites this paper
• Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs.

  2015cites this paper
• Prevalence, underlying mechanisms and role of nutrition in the management of the HIV-associated lipodystrophy syndrome

  2015influential citation
• Current topics in HIV-1 pathogenesis: The emergence of deregulated immuno-metabolism in HIV-infected subjects.

  2015cites this paper
• Lipid metabolism and lipodystrophy in HIV-1-infected patients: the role played by nonnucleoside reverse transcriptase inhibitors.

  2015cites this paper
• Microarray Analysis Reveals Altered Lipid and Glucose Metabolism Genes in Differentiated, Ritonavir-Treated 3T3-L1 Adipocytes.

  2015cites this paper
• Endocrinopathies in children infected with human immunodeficiency virus.

  2014cites this paper
• Can Progressive Resistive Exercise Improve Weight, Limb Girth, and Strength of Individuals With HIV Disease?

  2013cites this paper
• Antiretroviral Therapy (ART) Side Effect Impacted on Quality of Life, and Depressive Symptomatology: A Mixed-Method Study.

  2013cites this paper
• Dramatic Improvement in Physical Well-Being of Terminal AIDS Patients Following Administration of Phytochemicals

  2013cites this paper
• NRR volume 25 issue 2 Cover and Back matter

  2012cites this paper